Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nelmastobart + Capecitabine in Metastatic Colorectal Cancer
NCT05990543Phase 2Active, not recruiting
- Sponsor
- Korea University Anam Hospital
- Start
- Jan 2024
- Primary completion
- Dec 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nelmastobart in metastatic colorectal cancer (mCRC), sponsored by Korea University Anam Hospital. Started Jan 2024; status: active, not recruiting.
02
Drugs
nelmastobart
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT05990543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05990543.